{"id":67888,"date":"2024-09-15T14:45:00","date_gmt":"2024-09-15T12:45:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-provides-update-on-contact-02-phase-iii-trial-in-metastatic-castration-resistant-prostate-cancer-following-final-overall-survival-analysis-2946293\/"},"modified":"2024-09-16T09:29:34","modified_gmt":"2024-09-16T07:29:34","slug":"ipsen-provides-update-on-contact-02-phase-iii-trial-in-metastatic-castration-resistant-prostate-cancer-following-final-overall-survival-analysis-2946293","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-provides-update-on-contact-02-phase-iii-trial-in-metastatic-castration-resistant-prostate-cancer-following-final-overall-survival-analysis-2946293\/","title":{"rendered":"Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis"},"content":{"rendered":"